Topica Pharmaceuticals Lands $4,519,071 Series B Round

  • Feed Type
  • Date
    6/11/2013
  • Company Name
    Topica Pharmaceuticals
  • Mailing Address
    4300 El Camino Real Los Altos, CA 94022
  • Company Description
    Topica Pharmaceuticals, Inc. is a privately held, clinical-stage specialty pharmaceutical company focused exclusively on developing the first highly effective, safe and convenient topical treatment for onychomycosis, or fungal infections of the toenail and nail bed.
  • Website
    http://www.topicapharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,519,071
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing-amended.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.